NCT06833476View on ClinicalTrials.gov

TTVR STRONG Under Coverage With Evidence Development (CED) Study

RecruitingOBSERVATIONAL
Enrollment

2,044

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 31, 2032

Conditions
Tricuspid Regurgitation
Interventions
OTHER

EVOQUE

This is a retrospective, non-randomized study. The decision to intervene by TTVR with the EVOQUE device is made by the heart team.

Trial Locations (1)

92614

RECRUITING

Edwards Lifesciences, Irvine

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY